Stay updated with breaking news from Sciences Co. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Exact Sciences Co. (NASDAQ:EXAS – Get Free Report) have been given a consensus rating of “Moderate Buy” by the sixteen ratings firms that are presently covering the company, MarketBeat Ratings reports. Two analysts have rated the stock with a hold rating and fourteen have issued a buy rating on the company. The average […]
Exact Sciences Co. (NASDAQ:EXAS – Get Free Report) has been given an average rating of “Moderate Buy” by the sixteen research firms that are presently covering the stock, Marketbeat reports. Two analysts have rated the stock with a hold recommendation and fourteen have assigned a buy recommendation to the company. The average 12-month price objective […]
Lisanti Capital Growth LLC reduced its stake in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 71.8% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 20,720 shares of the medical research company’s stock after selling 52,810 shares […]
Knights of Columbus Asset Advisors LLC grew its holdings in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 2.1% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 71,842 shares of the medical research company’s stock after buying an additional 1,457 shares during […]
TD Asset Management Inc increased its stake in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 19.7% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 419,870 shares of the medical research company’s stock after buying an additional 69,071 […]